AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
RELATIONSHIP OF HEPATOCELLULAR CARCINOGENESIS WITH PRECORE MUTANT VIRUS AND SERUM HEPATITIS-B VIRUS-DNA CONCENTRATION - A LONGITUDINAL ANALYSIS OF PATIENTS WITH CIRRHOSIS
Authors: IKEDA K SAITOH S SUZUKI Y KOBAYASHI M TSUBOTA A FUKUDA M KOIDA I ARASE Y CHAYAMA K MURASHIMA N KUMADA H
Citation: K. Ikeda et al., RELATIONSHIP OF HEPATOCELLULAR CARCINOGENESIS WITH PRECORE MUTANT VIRUS AND SERUM HEPATITIS-B VIRUS-DNA CONCENTRATION - A LONGITUDINAL ANALYSIS OF PATIENTS WITH CIRRHOSIS, Hepatology research, 10(2), 1998, pp. 142-155
USEFULNESS OF HEPATITIS-C VIRUS-RNA COUNTS BY 2ND-GENERATION HCV BDNA-PROBE IN CHRONIC HEPATITIS-C BASED ON THE HCV GENOTYPE
Authors: KOBAYASHI M KUMADA H ARASE Y CHAYAMA K KOBAYASHI M TSUBOTA A KOIDA I SAITOH S SUZUKI Y MURASHIMA N IKEDA K MIYANO Y MIZOSHITA K MATSUDA M KOIKE H HASHIMOTO M
Citation: M. Kobayashi et al., USEFULNESS OF HEPATITIS-C VIRUS-RNA COUNTS BY 2ND-GENERATION HCV BDNA-PROBE IN CHRONIC HEPATITIS-C BASED ON THE HCV GENOTYPE, Journal of gastroenterology, 33(2), 1998, pp. 223-228
GLOMERULONEPHRITIS IN AUTOPSY CASES WITH HEPATITIS-C VIRUS-INFECTION
Authors: ARASE Y IKEDA K MURASHIMA N CHAYAMA K TSUBOTA A KOIDA I SUZUKI Y SAITOH S KOBAYASHI M KOBAYASHI M KOBAYASHI M KUMADA H
Citation: Y. Arase et al., GLOMERULONEPHRITIS IN AUTOPSY CASES WITH HEPATITIS-C VIRUS-INFECTION, Internal medicine, 37(10), 1998, pp. 836-840
BIOCHEMICAL AND HISTOLOGICAL FEATURES OF HEPATITIS-G VIRUS-INFECTION
Authors: KOBAYASHI M CHAYAMA K FUKUDA M TSUBOTA A SUZUKI Y ARASE Y KOIDA I SAITOH S MURASHIMA N IKEDA K KOIKE H HASHIMOTO M MIYANO Y KOBAYASHI M KUMADA H
Citation: M. Kobayashi et al., BIOCHEMICAL AND HISTOLOGICAL FEATURES OF HEPATITIS-G VIRUS-INFECTION, Journal of gastroenterology and hepatology, 13(8), 1998, pp. 767-772
PREDICTIVE FACTORS IN ERADICATING HEPATITIS-C VIRUS USING A RELATIVELY SMALL DOSE OF INTERFERON
Authors: FUKUDA M CHAYAMA K TSUBOTA A KOBAYASHI M HASHIMOTO M MIYANO Y KOIKE H KOBAYASHI M KOIDA I ARASE Y SAITOH S MURASHIMA N IKEDA K KUMADA H
Citation: M. Fukuda et al., PREDICTIVE FACTORS IN ERADICATING HEPATITIS-C VIRUS USING A RELATIVELY SMALL DOSE OF INTERFERON, Journal of gastroenterology and hepatology, 13(4), 1998, pp. 412-418
EMERGENCE AND TAKEOVER OF YMDD MOTIF MUTANT HEPATITIS-B VIRUS DURING LONG-TERM LAMIVUDINE THERAPY AND RE-TAKEOVER BY WILD-TYPE AFTER CESSATION OF THERAPY
Authors: CHAYAMA K SUZUKI Y KOBAYASHI M KOBAYASHI M TSUBOTA A HASHIMOTO M MIYANO Y KOIKE H KOBAYASHI M KOIDA I ARASE Y SAITOH S MURASHIMA N IKEDA K KUMADA H
Citation: K. Chayama et al., EMERGENCE AND TAKEOVER OF YMDD MOTIF MUTANT HEPATITIS-B VIRUS DURING LONG-TERM LAMIVUDINE THERAPY AND RE-TAKEOVER BY WILD-TYPE AFTER CESSATION OF THERAPY, Hepatology, 27(6), 1998, pp. 1711-1716
DISEASE PROGRESSION AND HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS - A PROSPECTIVE OBSERVATION OF 2215 PATIENTS
Authors: IKEDA K SAITOH S SUZUKI Y KOBAYASHI M TSUBOTA A KOIDA I ARASE Y FUKUDA M CHAYAMA K MURASHIMA N KUMADA H
Citation: K. Ikeda et al., DISEASE PROGRESSION AND HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS - A PROSPECTIVE OBSERVATION OF 2215 PATIENTS, Journal of hepatology, 28(6), 1998, pp. 930-938
A RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA IN PATIENTS WITH CIRRHOSIS CAUSED BY 2A 2B GENOTYPE HEPATITIS-C VIRUS/
Authors: IKEDA K KUMADA H SAITOH S SUZUKI Y KOBAYASHI M TSUBOTA A KOIDA I FUKUDA M ARASE Y CHAYAMA K MURASHIMA N TANGO T
Citation: K. Ikeda et al., A RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA IN PATIENTS WITH CIRRHOSIS CAUSED BY 2A 2B GENOTYPE HEPATITIS-C VIRUS/, Journal of hepatology, 28(5), 1998, pp. 910-911
DELETIONS IN THE HEPATITIS-B VIRUS CORE GENE MAY INFLUENCE THE CLINICAL OUTCOME IN HEPATITIS-B E-ANTIGEN POSITIVE ASYMPTOMATIC HEALTHY CARRIERS
Authors: TSUBOTA A KUMADA H TAKAKI K CHAYAMA K KOBAYASHI M KOBAYASHI M SUZUKI Y SAITOH S ARASE Y MURASHIMA N IKEDA K
Citation: A. Tsubota et al., DELETIONS IN THE HEPATITIS-B VIRUS CORE GENE MAY INFLUENCE THE CLINICAL OUTCOME IN HEPATITIS-B E-ANTIGEN POSITIVE ASYMPTOMATIC HEALTHY CARRIERS, Journal of medical virology, 56(4), 1998, pp. 287-293
INTERFERON DECREASES HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CIRRHOSIS CAUSED BY THE HEPATITIS-B VIRUS - A PILOT-STUDY
Authors: IKEDA K SAITOH S SUZUKI Y KOBAYASHI M TSUBOTA A FUKUDA M KOIDA I ARASE Y CHAYAMA K MURASHIMA N KUMADA H
Citation: K. Ikeda et al., INTERFERON DECREASES HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CIRRHOSIS CAUSED BY THE HEPATITIS-B VIRUS - A PILOT-STUDY, Cancer, 82(5), 1998, pp. 827-835
NUCLEOTIDE-SEQUENCES OF HEPATITIS GB VIRUS-C - IDENTIFICATION OF HIGHLY CONSERVED DOMAINS IN THE 5'-NONCODING REGION AND DETECTION BY POLYMERASE CHAIN-REACTION
Authors: CHAYAMA K MENON J OKAMOTO K HASHIMOTO M TSUBOTA A KOBAYASHI M MIYANO Y KOIKE H KOBAYASHI M KOIDA I ARASE Y SAITOH S SUZUKI Y MURASHIMA N IKEDA K KUMADA H
Citation: K. Chayama et al., NUCLEOTIDE-SEQUENCES OF HEPATITIS GB VIRUS-C - IDENTIFICATION OF HIGHLY CONSERVED DOMAINS IN THE 5'-NONCODING REGION AND DETECTION BY POLYMERASE CHAIN-REACTION, HEPATOLOGY RESEARCH, 6(5), 1997, pp. 225-232
EFFECT OF ARTERIAL ADMINISTRATION OF A HIGH-MOLECULAR-WEIGHT ANTITUMOR AGENT, STYRENE-MALEIC ACID NEOCARZINOSTATIN, FOR MULTIPLE SMALL LIVER-CANCER - A PILOT-STUDY
Authors: IKEDA K SAITOH S SUZUKI Y TSUBOTA A KOIDA I KOBAYASHI M ARASE Y CHAYAMA K MURASHIMA N KUMADA H
Citation: K. Ikeda et al., EFFECT OF ARTERIAL ADMINISTRATION OF A HIGH-MOLECULAR-WEIGHT ANTITUMOR AGENT, STYRENE-MALEIC ACID NEOCARZINOSTATIN, FOR MULTIPLE SMALL LIVER-CANCER - A PILOT-STUDY, Journal of gastroenterology, 32(4), 1997, pp. 513-520
HEPATITIS-G VIRUS-INFECTION AFTER BLOOD-TRANSFUSION IN PATIENTS WITH CHRONIC LIVER-DISEASE TREATED SURGICALLY FOR HEPATOCELLULAR-CARCINOMA
Authors: KOBAYASHI M CHAYAMA K ARASE Y FUKUDA M TSUBOTA A SUZUKI Y KOIDA I SAITOH S MURASHIMA N IKEDA K KOIKE H HASHIMOTO M MIYANO Y KOBAYASHI M KUMADA H
Citation: M. Kobayashi et al., HEPATITIS-G VIRUS-INFECTION AFTER BLOOD-TRANSFUSION IN PATIENTS WITH CHRONIC LIVER-DISEASE TREATED SURGICALLY FOR HEPATOCELLULAR-CARCINOMA, International hepatology communications, 9(1), 1997, pp. 28-36
A PROSPECTIVE RANDOMIZED ADMINISTRATION OF 5'-DEOXY-5-FLUOROURIDINE AS ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
Authors: IKEDA K SAITOH S SUZUKI Y KOIDA I TSUBOTA A KOBAYASHI M ARASE Y CHAYAMA K MURASHIMA N KUMADA H
Citation: K. Ikeda et al., A PROSPECTIVE RANDOMIZED ADMINISTRATION OF 5'-DEOXY-5-FLUOROURIDINE AS ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION, American journal of clinical oncology, 20(2), 1997, pp. 202-208
PRETREATMENT VIRUS LOAD AND MULTIPLE AMINO-ACID SUBSTITUTIONS IN THE INTERFERON SENSITIVITY-DETERMINING REGION PREDICT THE OUTCOME OF INTERFERON TREATMENT IN PATIENTS WITH CHRONIC GENOTYPE 1B HEPATITIS-C VIRUS-INFECTION
Authors: CHAYAMA K TSUBOTA A KOBAYASHI M OKAMOTO K HASHIMOTO M MIYANO Y KOIKE H KOBAYASHI M KOIDA I ARASE Y SAITOH S SUZUKI Y MURASHIMA N IKEDA K KUMADA H
Citation: K. Chayama et al., PRETREATMENT VIRUS LOAD AND MULTIPLE AMINO-ACID SUBSTITUTIONS IN THE INTERFERON SENSITIVITY-DETERMINING REGION PREDICT THE OUTCOME OF INTERFERON TREATMENT IN PATIENTS WITH CHRONIC GENOTYPE 1B HEPATITIS-C VIRUS-INFECTION, Hepatology, 25(3), 1997, pp. 745-749
TIME-COURSE OF HISTOLOGICAL-CHANGES IN PATIENTS WITH A SUSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-C VIRUS-INFECTION
Authors: TSUBOTA A KUMADA H CHAYAMA K ARASE Y SAITOH S KOIDA I SUZUKI Y KOBAYASHI M MURASHIMA N IKEDA K
Citation: A. Tsubota et al., TIME-COURSE OF HISTOLOGICAL-CHANGES IN PATIENTS WITH A SUSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-C VIRUS-INFECTION, Journal of hepatology, 27(1), 1997, pp. 49-55
THE LONG-TERM EFFICACY OF GLYCYRRHIZIN IN CHRONIC HEPATITIS-C PATIENTS
Authors: ARASE Y IKEDA K MURASHIMA N CHAYAMA K TSUBOTA A KOIDA I SUZUKI Y SAITOH S KOBAYASHI M KUMADA H
Citation: Y. Arase et al., THE LONG-TERM EFFICACY OF GLYCYRRHIZIN IN CHRONIC HEPATITIS-C PATIENTS, Cancer, 79(8), 1997, pp. 1494-1500
HEPATITIS-C VIRUS SUBTYPE 3B INFECTION IN A HOSPITAL IN JAPAN - EPIDEMIOLOGIC-STUDY
Authors: IKEDA K CHAYAMA K SAITOH S KOIDA I SUZUKI Y TSUBOTA A KOBAYASHI M ARASE Y MURASHIMA N KUMADA H
Citation: K. Ikeda et al., HEPATITIS-C VIRUS SUBTYPE 3B INFECTION IN A HOSPITAL IN JAPAN - EPIDEMIOLOGIC-STUDY, Journal of gastroenterology, 31(6), 1996, pp. 801-805
A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF NATURAL INTERFERON-BETA THERAPY FOR E-ANTIGEN-NEGATIVE CHRONIC HEPATITIS-B PATIENTS WITH ABNORMAL TRANSAMINASE LEVELS
Authors: ARASE Y CHAYAMA K TSUBOTA A MURASHIMA N SUZUKI Y KOIDA I KOBAYASHI M SAITOH S IKEDA K KUMADA H KOBAYASHI M SUZUKI H
Citation: Y. Arase et al., A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF NATURAL INTERFERON-BETA THERAPY FOR E-ANTIGEN-NEGATIVE CHRONIC HEPATITIS-B PATIENTS WITH ABNORMAL TRANSAMINASE LEVELS, Journal of gastroenterology, 31(4), 1996, pp. 559-564
A PILOT-STUDY OF CORTICOSTEROID PRIMING FOR LYMPHOBLASTOID INTERFERON-ALFA IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: CHAYAMA K TSUBOTA A KOBAYASHI M HASHIMOTO M MIYANO Y KOIKE H KOBAYASHI M KOIDA I ARASE Y SAITOH S MURASHIMA N IKEDA K KUMADA H
Citation: K. Chayama et al., A PILOT-STUDY OF CORTICOSTEROID PRIMING FOR LYMPHOBLASTOID INTERFERON-ALFA IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 23(5), 1996, pp. 953-957
RELATIONSHIP BETWEEN PRETREATMENT VIREMIA LEVEL AND RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-C DIFFERS IN VIRAL TYPE-1 ANDTYPE-2 INFECTIONS
Authors: TSUBOTA A KUMADA H CHAYAMA K ARASE Y SAITOH S KOIDA I MURASHIMA N SUZUKI Y KOBAYASHI M TAKAGI K KOBAYASHI M IKEDA K
Citation: A. Tsubota et al., RELATIONSHIP BETWEEN PRETREATMENT VIREMIA LEVEL AND RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-C DIFFERS IN VIRAL TYPE-1 ANDTYPE-2 INFECTIONS, Digestive diseases and sciences, 41(10), 1996, pp. 1925-1932
NOVEL HEPATITIS-B VARIANTS IN SIBLING CARRIERS POSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN
Authors: SUZUKI F CHAYAMA K KOBAYASHI M TSUBOTA A KOIDA I SAITOH S ARASE Y MURASHIMA N IKEDA K KUMADA H
Citation: F. Suzuki et al., NOVEL HEPATITIS-B VARIANTS IN SIBLING CARRIERS POSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN, HEPATOLOGY RESEARCH, 4(3), 1995, pp. 121-125
USEFULNESS OF HCV-RNA COUNTS BY THE METHOD OF HCV-BDNA PROBE IN INTERFERON RETREATMENT FOR PATIENTS WITH HCV-RNA POSITIVE CHRONIC HEPATITIS-C
Authors: ARASE Y KUMADA H CHAYAMA K NAOYA M TSUBOTA A KOIDA I KOBAYASHI M SUZUKI Y IKEDA K SAITOH S KOBAYASHI M
Citation: Y. Arase et al., USEFULNESS OF HCV-RNA COUNTS BY THE METHOD OF HCV-BDNA PROBE IN INTERFERON RETREATMENT FOR PATIENTS WITH HCV-RNA POSITIVE CHRONIC HEPATITIS-C, HEPATOLOGY RESEARCH, 4(1), 1995, pp. 19-25
A PROSPECTIVE RANDOMIZED EVALUATION OF A COMPOUND OF TEGAFUR AND URACIL AS AN ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
Authors: IKEDA K SAITOH S KOIDA I TSUBOTA A ARASE Y CHAYAMA K KUMADA H
Citation: K. Ikeda et al., A PROSPECTIVE RANDOMIZED EVALUATION OF A COMPOUND OF TEGAFUR AND URACIL AS AN ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION, American journal of clinical oncology, 18(3), 1995, pp. 204-210
SERIAL HEMODYNAMIC MEASUREMENTS IN WELL-DIFFERENTIATED HEPATOCELLULARCARCINOMAS
Authors: SAITOH S IKEDA K KOIDA I TSUBOTA A ARASE Y CHAYAMA K KUMADA H
Citation: S. Saitoh et al., SERIAL HEMODYNAMIC MEASUREMENTS IN WELL-DIFFERENTIATED HEPATOCELLULARCARCINOMAS, Hepatology, 21(6), 1995, pp. 1530-1534
Risultati: 1-25 | 26-45